BioAtla (BCAB) Times Interest Earned (2020 - 2026)
BioAtla (BCAB) posted quarterly Times Interest Earned of -$465.4 for Q1 2026, down 660.96% year-over-year from $82.97 in Q1 2025, and down 5371.12% quarter-over-quarter from -$8.51 in Q3 2025.
BioAtla (BCAB) Times Interest Earned (2020 - 2026) Analysis & Trends
BioAtla's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$465.4 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 660.96% year-over-year to -$465.4; the TTM figure through Mar 2026 stood at -$51.57 (down 5.21% YoY), while the FY2025 annual figure was -$0.51, up 28.98% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$465.4, down from -$8.51 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.01 in Q3 2022, with the low at -$3248.8 in Q4 2024.
- The 5-year median for Times Interest Earned is -$27.21 (2024), against an average of -$260.1.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned soared 99.99% in 2022, then sank 432668.98% in 2023.
- BioAtla's Times Interest Earned stood at -$71.4 in 2022, then sank by 45.86% to -$104.15 in 2023, then tumbled by 3019.47% to -$3248.8 in 2024, then soared by 99.74% to -$8.51 in 2025, then slumped by 5371.12% to -$465.4 in 2026.
- Business Quant data shows BCAB's Times Interest Earned at -$465.4 in Q1 2026, -$8.51 in Q3 2025, and -$2.37 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - | 20.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | -465.40 |
| Sep 30, 2025 | -8.51 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -61.16 |
| Dec 31, 2024 | -3,248.80 |
| Sep 30, 2024 | -8.87 |
| Jun 30, 2024 | -12.97 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -104.15 |
| Sep 30, 2023 | -41.44 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -71.08 |
| Dec 31, 2022 | -71.40 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.47 |
| Mar 31, 2022 | -64.58 |
| Dec 31, 2021 | -17.13 |
| Sep 30, 2021 | -64.04 |
| Jun 30, 2021 | -2.00 |